Cardiotoxicity in children after bone marrow transplantation

Pediatric Hematology and Oncology

Volumn 17, Issue 3, 2000, Pages 203-209

  Nicolini, B ^a   Rovelli, A ^a   Uderzo, Cornelio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Bone marrow transplantation; Cardiotoxicity; Cyclophosphamide; Late effects; Total body irradiation

Indexed keywords

CYCLOPHOSPHAMIDE;

BONE MARROW TRANSPLANTATION; CANCER RADIOTHERAPY; CARDIOTOXICITY; CHILD; HEART FUNCTION; HEART INJURY; HUMAN; PRESCHOOL CHILD; REVIEW; SCHOOL CHILD; STEM CELL TRANSPLANTATION; WHOLE BODY RADIATION;

EID: 0034107319     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800100276370     Document Type: Review

References (31)

1. Sanders JE. Bone marrow trasplantation for pediatric leukemia. Pediatrics. 1991;20:671-676.
2. Sanders JE. Late effects following marrow transplantation. In: Johnson FL, Pochedly C, eds. Bone Marrow Transplantation in Children. New York: Raven Press; 1990:471-496.
3. Pihkala J, Saarinen UM, Lundstrom U, et al. Effects of bone marrow transplantation on myocardial function in children. Bone Marrow Transplant. 1994;13:149-155.
4. Parillo JE. Cardiovascular dysfunction in septic shock: new insights into a deadly disease. Int J Cardiol. 1985;7:314-321.
5. Kupari M, Volin L, Suokas A, et al. Cardiac involvement in bone marrow transplantation: electrocardiographic changes, arrhythmias, heart failure and autopsy findings. Bone Marrow Trasplant. 1990;5:91-98.
6. Hale JP, Lewis IJ. Anthracyclines: cardiotoxicity and its prevention. Arch Dis Child. 1994;71:457-462.
7. Steinherz LJ, Steinherz PG, Tan C. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med Pediatr Oncol. 1995;24:352-361.
8. Lipshultz SE, Sanders SP, Goorin AM, et al. Monitoring for anthracycline cardiotoxicity. Pediatrics. 1994;93:433-437.
9. Jakacki RI, Larsen RL, Barber G, et al. Comparison of cardiac function tests after anthracyclines therapy in childhood. Cancer. 1993;72:2739-2745.
10. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
11. Stewart JR, Fajardo LF. Radiation-induced heart disease: an update. Prog Cardiovasc Dis. 1984;27: 173-194.
12. Arsenian MA. Cardiovascular sequelae of therapeutic thoracic radiation. Prog Cardiovasc Dis. 1991;33: 299-312.
13. Carlson RG, Mayfield WR, Normann S, et al. Radiation associated valvular disease. Chest. 1991;99: 538-545.
14. Pohjola-Sintonen S, Totterman KJ, Kupari M. Sick sinus syndrome as a complication of mediastinal radiation therapy. Cancer. 1990;65:2494-2496.
15. Slama HS, Le Guludec D, Sebag C, et al. Complete atrioventricular block following mediastinal irradiation: a report of six cases. PACE Pacing Clin Electrophysiol. 1991;14:1112-1118.
16. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation. 1993;87:1435-1441.
17. Lipshultz SE, Sallan SE. Cardiovascular abnormalities in long-term survivors of childhood malignancy. J Clin Oncol. 1993;11:1199-1203.
18. Gardner SF, Lazarus HM, Bednarczyk EM, et al. High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography. Bone Marrow Transplant. 1993;12:139-144.
19. Bearman SI, Petersen FB, Schor RA, et al. Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity. Bone Marrow Transplant. 1990;5:173-177.
20. Steinherz LJ, Steinherz PG, Mangiacasale D, et al. Cardiac changes with cyclophosphamide. Med Pediatr Oncol. 1981;9:417-422.
21. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986;68:1114-1118.
22. Gottdeiner JS, Appelbaum FR, Ferrans VJ, et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med. 1981;141:758-763.
23. Peterson FB, Bearman SC. Preparative regimens and their toxicity. Bone Marrow Transplant. 1994;8: 79-92.
24. Ross J. Control of cardiac performance. In: Bernc RM, Sperelakis N, Geiger SR, eds. Handbook of Physiology: The Cardiovascular System. Baltimore: Williams & Wilkins, 1979;1:533-580.
25. Ross J. Afterload mismatch and preload reserve: a conceptual framework for the analysis of ventricular function. Prog Cardiovasc Dis. 1976;18:255-264.
26. Weber KT, Janicki JS. The heart as a muscle-pump system and the concept of heart failure. Am Heart J. 1979;98:371-384.
27. Borow KM. Clinical assessment of contractility in the symmetrically contracting left ventricle. Mod Concepts Cardiovasc Dis. 1988;57:29-34.
28. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-815.
29. Pohjola-Sintonen S, Totterman KJ, Salmo H, et al. Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease. Cancer. 1987;60:37 (abstr.).
30. Rovelli A, Pezzini C, Silvestri D, et al. Cardiac and respiratory function after bone marrow transplantation in children with leukemia. Bone Marrow Transplant. 1995;16:571-576.
31. EBMT Late Effects Working Party (WPLE). Guidelines for evaluation of late effects of hematopoietic cell transplantation. In: European Group for Blood and Marrow Transplantation, Operational Manual, 1999:59.